U.S. markets closed
  • S&P Futures

    3,949.50
    +4.50 (+0.11%)
     
  • Dow Futures

    33,675.00
    +42.00 (+0.12%)
     
  • Nasdaq Futures

    11,583.00
    +17.00 (+0.15%)
     
  • Russell 2000 Futures

    1,815.50
    +1.40 (+0.08%)
     
  • Crude Oil

    74.15
    -0.10 (-0.13%)
     
  • Gold

    1,783.50
    +1.10 (+0.06%)
     
  • Silver

    22.40
    +0.06 (+0.27%)
     
  • EUR/USD

    1.0465
    -0.0004 (-0.04%)
     
  • 10-Yr Bond

    3.5130
    -0.0860 (-2.39%)
     
  • Vix

    22.17
    +1.42 (+6.84%)
     
  • GBP/USD

    1.2134
    +0.0001 (+0.01%)
     
  • USD/JPY

    137.1630
    +0.2030 (+0.15%)
     
  • BTC-USD

    17,036.21
    -11.45 (-0.07%)
     
  • CMC Crypto 200

    401.95
    +0.14 (+0.04%)
     
  • FTSE 100

    7,521.39
    -46.15 (-0.61%)
     
  • Nikkei 225

    27,756.94
    -128.93 (-0.46%)
     

Petmed Express Shares Plunge On Q1 Earnings Miss

  • Petmed Express Inc (NASDAQ: PETS) reported a first-quarter FY22 sales decline of 11.5% year-on-year, to $70.20 million, missing the analyst consensus estimate of $78.25 million.

  • The gross profit for the quarter declined 8.4% Y/Y to $19.9 million, and the gross margin contracted 90 basis points to 28.4%.

  • The operating margin was 5%, and operating income for the quarter fell 35.6% to $3.4 million.

  • The company held $105.4 million in cash and equivalents as of June 30, 2022. Cash provided by operating activities for the quarter totaled $6.4 million.

  • Adjusted EBITDA decreased 10% Y/Y to $6.3 million.

  • Adjusted EPS of $0.14 missed the analyst consensus of $0.25.

  • "We knew early in the quarter that the colder temperatures, particularly in April, would have a material impact on sales due to the delay in our seasonally sensitive flea and tick business," said CEO Matt Hulett.

  • The Board of Directors declared a quarterly dividend of $0.30 per share, payable on August 19, 2022, to shareholders of record at the close of business on August 12, 2022.

  • Price action: PETS shares are trading lower by 10.60% at $18.51 in premarket on the last check Tuesday.

See more from Benzinga

Don't miss real-time alerts on your stocks - join Benzinga Pro for free! Try the tool that will help you invest smarter, faster, and better.

© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.